Virtual Medicinal Product (VMP) - Co-amoxiclav 250mg/62mg/5ml oral suspension
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Co-amoxiclav 250mg/62mg/5ml oral suspension | Start Date 18-11-2004 | End Date |
| Previous Name | Previous Name Co-amoxiclav 250mg/62mg oral suspension | Start Date 04-05-2004 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 5
- UDFS UOM
- ml
- Unit Dose UOM
- spoonful
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Non-availability Indicator
- Actual Products Available
- Name Basis
- BAN - British Approved Name
Codes
- ATC Code
- J01CR02
| BNF | Start Date | End Date |
|---|---|---|
| Current BNF 05010103 | Start Date 04-04-2022 | End Date |
| Previous BNF 05010103 | Start Date 01-02-2005 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 7322311000001107 | 02-04-2004 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Amoxicillin trihydrate | Based on Base Substance | Amoxicillin | 50 mg | 1 ml |
| Potassium clavulanate | Based on Base Substance | Clavulanic acid | 12.5 mg | 1 ml |
Name
Amoxicillin trihydrate
Basis of strength description
Based on Base Substance
BOSS
Amoxicillin
Strength and UOM (Nmr)
50
Strength and UOM (Dmr)
1
Name
Potassium clavulanate
Basis of strength description
Based on Base Substance
BOSS
Clavulanic acid
Strength and UOM (Nmr)
12.5
Strength and UOM (Dmr)
1
Parent Products
-
VTMCo-amoxiclav
-
VMP(Current) Co-amoxiclav 250mg/62mg/5ml oral sus...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 100 ml | 360 | Part VIIIA Category C |